Unlabelled: Pleural effusion is acumulation of liquid in pleural space, wich caused primary of pleural diseases or secundary of systemic diseases.
Problem: Pleural effusion are the most frequently caused by malignancy and make worse poor condition of patients with malignancy. Pleural punction is insufficient metod for treatmen of malignancy pleural effusion. The best modefor treatment is pleurodesis using Doxicyclin.
Patients And Methods: There are embrased all patient hospitalized in thoracis surgery department of KCU Sarajevo in period may 1999. - septembar 2002. whole medicaly treatet in procedure of chemical pleurodesis because of malignant pleural effusion. Examinee group of patients are medicaly treatet in procedure of chemical pleurodesis. Control group of patients are medicaly treatet by pleural punction because of malignanacy pleural effusion, same diseases in both group of patients. The results are present textualy, numberly and graphic printing.
Results: Procedure of chemical pleurodesis obtained in mostly patients obliteration of pleural space, and prevent reaccumulation of pleural effusion. Procedure of chemical pleurodesis make quality of life better, complications are rare, mortality conect with procedure is not exist.
Download full-text PDF |
Source |
---|
Radiol Artif Intell
January 2025
From the Department of Radiology (E.J.H., S.K., H.K., D. K., S.H.Y.) and Medical Research Collaborating Center (H.H.), Seoul National University Hospital, 101 Daehak- ro, Jongno-gu, Seoul 03080, Korea; Department of Radiology, Seoul National University College of Medicine (E.J.H., H.K., S.H.Y.), Seoul, Korea; Department of Radiology, Hanyang University Medical Center, Hanyang University College of Medicine (S-J.Y., Seoul, Korea).
Quantifying pleural effusion change on chest CT is important for evaluating disease severity and treatment response. The purpose of this study was to assess the accuracy of artificial intelligence (AI)-based volume quantification of pleural effusion change on CT images, using the volume of drained fluid as the reference standard. Seventy-nine participants (mean age, 65 ± [SD] 13 years; 47 male) undergoing thoracentesis were prospectively enrolled from October 2021 to September 2023.
View Article and Find Full Text PDFMicrobiol Spectr
January 2025
Sunshine Coast Health Institute, Birtinya, Queensland, Australia.
Pleural infections are common and associated with substantial healthcare costs, morbidity, and mortality. Accurate diagnosis remains challenging due to low culture positivity rates, frequent polymicrobial involvement, and non-specific diagnostic biomarkers. Here, we undertook a prospective study examining the feasibility and performance of molecular methods for diagnosing suspected pleural infection.
View Article and Find Full Text PDFCureus
December 2024
Pediatric Intensive Care Unit, King Fahad Medical City, Riyadh, SAU.
Background: High-flow nasal cannula (HFNC) therapy has developed as a valuable tool for respiratory support in pediatric critical care. It offers an intermediate level of support between traditional low-flow oxygen and non-invasive ventilation (NIV). Studies suggest its effectiveness in improving oxygen delivery, work of breathing, and secretion clearance.
View Article and Find Full Text PDFCancer Cell Int
January 2025
Department of Immuno-Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, China.
Background: Patients with lung adenocarcinoma (LUAD) receiving drug treatment often have an unpredictive response and there is a lack of effective methods to predict treatment outcome for patients. Dendritic cells (DCs) play a significant role in the tumor microenvironment and the DCs-related gene signature may be used to predict treatment outcome. Here, we screened for DC-related genes to construct a prognostic signature to predict prognosis and response to immunotherapy in LUAD patients.
View Article and Find Full Text PDFMedicine (Baltimore)
November 2024
Pneumology Department, Baoding People's Hospital, Baoding, Hebei, China.
This study examines the diagnostic utility of the combined interleukin-33 (IL-33), interferon-γ (IFN-γ), and interleukin-35 (IL-35) test in tuberculous pleural effusion. Forty patients with pleural effusion of unknown etiology admitted to the hospital between December 2020 and December 2023 were selected as the study group. The patients were further categorized into tuberculous (TB) (n = 20) and malignant (n = 20) groups on the basis of their relevant data, while sera from 20 healthy medical checkups were used as control group.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!